Stock 6990 SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Equities

6990

CNE1000062J1

Biotechnology & Medical Research

Delayed Hong Kong S.E.
Other stock markets
 02:55:53 2024-05-23 am EDT 		5-day change 1st Jan Change
173.9 HKD -3.92% Intraday chart for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. +0.64% +69.00%
May. 08 Sichuan Kelun-biotech Biopharmaceutical to Place 3.6 Million Shares; Inks Subscription Deal for 4.4 Million Shares MT
May. 06 Kelun-Biotech's Lung Cancer Drug Advances to Phase 2 Trials in US; Shares Up 8% MT

Business Summary

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.

Number of employees: 1,446

Sales per Business

HKD in Million2022Weight2023Weight Delta
Novel Drugs
100.0 %
935 100.0 % 1,702 100.0 % +82.08%

Sales per region

HKD in Million2022Weight2023Weight Delta
United States
99.2 %
849 90.8 % 1,689 99.2 % +98.92%
China
0.5 %
66 7.0 % 8 0.5 % -87.31%
Other Countries
0.3 %
20 2.2 % 5 0.3 % -74.20%

Managers

Managers TitleAgeSince
Jun You Ge CEO
 Chief Executive Officer 51 21-02-07
Ze Jian Zhou DFI
 Director of Finance/CFO 41 22-02-24
Xiang Yang Tan CTO
 Chief Tech/Sci/R&D Officer 61 21-07-04
Xiao Ping Jin CTO
 Chief Tech/Sci/R&D Officer 47 21-09-05
Yi Wei Zhang PRN
 Corporate Officer/Principal 68 18-01-08
Yi Feng PRN
 Corporate Officer/Principal 59 20-11-30
Wai Sum Fung SEC
 Corporate Secretary 41 23-01-29

Members of the board

Members of the board TitleAgeSince
Ge Xin Liu FOU
 Founder 73 16-11-21
Yue Dong Li BRD
 Director/Board Member 47 23-02-14
Si Chuan Liu BRD
 Director/Board Member 40 16-11-21
Hao Feng BRD
 Director/Board Member 44 21-02-11
Jun You Ge CEO
 Chief Executive Officer 51 21-02-07
Yi Hong Liao BRD
 Director/Board Member 44 22-02-24
Dong Fang Li BRD
 Director/Board Member 36 22-02-24
Hong Mei Song BRD
 Director/Board Member 41 19-05-17
Qiu Yan Yang BRD
 Director/Board Member 39 17-08-17
Yan Qing BRD
 Director/Board Member 40 20-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 92,571,094 91,645,383 ( 99.00 %) 0 55.98 %
Stock B 1 130,273,005 33,107,580 ( 25.41 %) 0

Shareholders

NameEquities%Valuation
SICHUAN KELUN PHARMACEUTICAL CO., LTD.
56.34 %
71,345,543 56.34 % 1 535 M $
MERCK & CO., INC.
10.62 %
13,443,693 10.62 % 289 M $
IDG Capital Partners Co., Ltd.
3.666 %
4,642,191 3.666 % 100 M $
Jun Li
3.317 %
4,200,000 3.317 % 90 M $
Wellington Management Group LLP
2.282 %
2,889,419 2.282 % 62 M $
Jing Yi Wang
2.251 %
2,850,000 2.251 % 61 M $
RTW Investments LP
1.528 %
1,934,400 1.528 % 42 M $
Wellington Management Hong Kong Ltd.
0.8860 %
1,121,841 0.8860 % 24 M $
China Universal Asset Management Co., Ltd.
0.8535 %
1,080,700 0.8535 % 23 M $
Trumed Health Partners LLC
0.7420 %
939,600 0.7420 % 20 M $
NameEquities%Valuation
SICHUAN KELUN PHARMACEUTICAL CO., LTD.
52.66 %
78,777,842 52.66 % 1 695 M $
Jing Yi Wang
1.905 %
2,850,000 1.905 % 61 M $
Jun You Ge
0.9827 %
1,470,000 0.9827 % 32 M $
Hong Mei Song
0.2106 %
315,000 0.2106 % 7 M $
De Gui Lai
0.1965 %
294,000 0.1965 % 6 M $
Hao Feng
0.1965 %
294,000 0.1965 % 6 M $
Yan Qing
0.1872 %
280,000 0.1872 % 6 M $
Qiu Yan Yang
0.1497 %
224,000 0.1497 % 5 M $

Company contact information

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

No. 666 Xinhua Avenue Chengdu Cross-Strait Science and

611100, Chengdu

+

address Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.(6990)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per region

Ratings for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
181 HKD
Average target price
184 HKD
Spread / Average Target
+1.68%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. Stock Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
+69.00% 5.17B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.99% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.01% 106B
BIONTECH SE Stock BioNTech SE
-3.07% 24.69B
ARGENX SE Stock argenx SE
-0.32% 21.97B
GENMAB A/S Stock Genmab A/S
-4.64% 19.27B
BEIGENE, LTD. Stock BeiGene, Ltd.
-6.90% 17.56B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.36% 17.32B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.82% 14.03B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.05% 12.13B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 6990 Stock
  4. Company Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.